复苏后穿透伤手术治疗研究:后颅窝穿透性损伤的新分类系统
这项回顾性研究评估了仅基于弹道轨迹特征的STOPWAR后颅窝穿透性创伤性脑损伤分类方案,纳入2022年2月24日至2024年5月2日期间抵达乌克兰第聂伯罗Mechnikov第聂伯罗彼得罗夫斯克地区临床医院的71例连续后颅窝穿透伤患者,分析该分类与1个月死亡率及1个月二分格拉斯哥结局量表(GOS)结局的关系。结果显示1个月死亡率为21%,STOPWAR分类对1个月死亡率的AUC为0.9298、OR为4.054(95%CI 2.287-9.126),对1个月二分GOS结局的AUC为0.8373、OR为3.154(95%CI 1.954-5.830),性能与其他评估的TBI分类方案相当。
要点
- STOPWAR分类仅基于影像学弹道轨迹特征,临床检查不可行或不准确时仍可使用。
- 71例后颅窝穿透伤患者1个月死亡率为21%,低于其他已发表系列。
- STOPWAR对1个月死亡率AUC为0.9298,OR为4.054(95%CI 2.287-9.126)。
核心结论
- 在已报道的最大后颅窝穿透性TBI系列中,1个月死亡率低于其他已发表系列,提示以弹片伤为主的军事穿透性TBI患者结局可能优于以枪弹伤为主的平民穿透性TBI患者。
- STOPWAR分类系统表现良好,其主要优势是仅基于影像学发现,可在临床检查不可行或可能不准确时使用。
- STOPWAR对GOS结局的表现略差于对死亡率的表现,可能反映在伤后1个月早期时间点使用GOS作为结局指标的不充分性。
- 目前乌克兰无法进行伤后更长间隔的更详细结局评估,这些及其他研究设计改进可在未来研究中探索,未来研究还可评估STOPWAR量表在平民穿透性TBI患者和其他武装冲突伤员中的作用。
研究设计与样本
- 回顾性研究,评估仅基于弹道轨迹特征的STOPWAR后颅窝穿透性TBI分类方案。
- 连续纳入2022年2月24日至2024年5月2日期间抵达乌克兰第聂伯罗Mechnikov第聂伯罗彼得罗夫斯克地区临床医院的71例后颅窝穿透伤患者。
- 采用单变量和多变量分析检验STOPWAR分类与1个月死亡率及1个月二分GOS结局的关系,并评估其他TBI分类和预后方案。
主要发现
- 本系列1个月死亡率为21%。
- STOPWAR分类对1个月死亡率的AUC为0.9298,OR为4.054(95%CI 2.287-9.126)。
- STOPWAR分类对1个月二分GOS结局的AUC为0.8373,OR为3.154(95%CI 1.954-5.830)。
- STOPWAR分类的性能与所评估的其他TBI分类方案相当。
关键数值与推荐
- STOPWAR分类仅基于弹道轨迹特征。
- STOPWAR分类对1个月死亡率AUC为0.9298,OR为4.054(95%CI 2.287-9.126)。
- STOPWAR分类对1个月二分GOS结局AUC为0.8373,OR为3.154(95%CI 1.954-5.830)。
临床怎么用
- STOPWAR量表仅基于影像学发现,可在临床检查不可行或可能不准确时使用。
- 作者认为STOPWAR分类系统表现良好。
局限性
- STOPWAR对GOS结局的表现略差于对死亡率的表现,可能反映在伤后1个月早期时间点使用GOS作为结局指标的不充分性。
- 目前乌克兰无法进行伤后更长间隔的更详细结局评估。
- 这些及其他研究设计改进可在未来研究中探索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The goal of this retrospective study was to evaluate the new Surgical Treatment of Penetrating Wounds After Resuscitation (STOPWAR) posterior fossa penetrating traumatic brain injury (pTBI) classification scheme, which is based only on features of the projectile trajectory. METHODS: This retrospective investigation evaluated a consecutive series of 71 patients with penetrating posterior fossa injuries who arrived at Mechnikov Dnipropetrovsk Regional Clinical Hospital in Dnipro, Ukraine, between February 24, 2022, and May 2, 2024. Univariable and multivariable analyses were performed to examine the relationships between STOPWAR classification and 1-month mortality as well as 1-month outcome on the dichotomized Glasgow Outcome Scale (GOS). Other classification and prognostic schemes for patients with traumatic brain injury (TBI) were also evaluated. RESULTS: The 1-month mortality rate in this series was 21%. The STOPWAR classification scheme had an area under the receiver operating characteristic curve (AUC) of 0.9298 and OR of 4.054 (95% CI 2.287-9.126) for 1-month mortality and an AUC of 0.8373 and OR of 3.154 (95% CI 1.954-5.830) for 1-month dichotomized GOS outcome. This performance was comparable to that of the other TBI classification schemes that were evaluated. CONCLUSIONS: In the largest reported series of patients with posterior fossa pTBI, 1-month mortality was lower than that in other published series, suggesting that patients with military pTBI, which is caused primarily by shrapnel, may have a better outcome than those with civilian pTBI, most of whom have gunshot wounds. The STOPWAR classification system performed well. A major advantage of the STOPWAR scale is that it is based only on imaging findings and may be used when clinical examination is impossible or potentially inaccurate. The slightly worse performance of the STOPWAR scheme for GOS outcome than for mortality may reflect the inadequacy of using the GOS as an outcome metric at the early postinjury time point of 1 month. Unfortunately, more detailed outcome assessments at longer postinjury time intervals are currently not possible in Ukraine. These and other improvements in study design can be explored in future investigations, which may also evaluate the role of the STOPWAR scale in civilian pTBI patients and in casualties from other armed conflicts.
引用
- Sirko A, Traylor JI, Hicks WH, et al. Surgical Treatment of Penetrating Wounds After Resuscitation study: a new classification system for penetrating injuries to the posterior fossa. J Neurosurg. 2025. PMID: 40279709. doi:10.3171/2025.1.JNS242420
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。